Charterhouse Capital Partners, a private equity investment firm, completed the investment in PHASTAR, a biometrics contract research organization. Financial terms were not disclosed. “I am delighted to be partnering with Charterhouse and Nick Edwards to support PHASTAR in the next phase of its growth. This investment comes at an ideal time for the business, with growth accelerating and new offices opening in Japan and China. We are grateful for the support shown by our clients and team members over the past thirteen years, and look forward to cementing PHASTAR’s position as a partner of choice for pharmaceutical companies in their most important statistical and data projects," Kevin Kane, PHASTAR Founder and CEO.